Cobio Diagnostics Inc.
Aurora, CO Doing business as Cobio Diagnostics Inc.
- UEI
- DNNKH7TPCUG3
- CAGE
- 8FHN6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 12635 E Montview Blvd Rm 219, Aurora, CO 80045, USA
- Website
- cobio.co
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Fast-track phage-amplified maldi-TOF MS for rapid phenotypic UTI diagnosis and antimicrobial susceptibility testing -… | National Institute of Diabetes and Digestive and Kidney Diseases | $306,867 | |
| Sbir phase II: phage-amplified identification and antimicrobial susceptibility test -the broader impact of this small… | National Science Foundation | $984,381 | |
| Sbir phase i: phage-amplified identification and antimicrobial susceptibility test | Division of Industrial Innovation | $256,000 | |
| Rapid phage-amplified immunoassay for phenotypic UTI diagnosis and antimicrobial susceptibility testing - abstract/… | National Institute of Diabetes and Digestive and Kidney Diseases | $2,476,225 | |
| Rapid phage-amplified immunoassay for phenotypic UTI diagnosis and antimicrobial susceptibility testing | National Institute of Diabetes and Digestive and Kidney Diseases | $250,617 |
About Cobio Diagnostics Inc.
Cobio Diagnostics Inc. is a for-profit corporate entity based in Aurora, Colorado, registered in the System for Award Management (SAM) since November 2019, with registration valid through March 2026. The company appears to specialize in developing advanced diagnostic technologies focused on rapid microbial identification and antimicrobial susceptibility testing, with a particular emphasis on innovative bacteriophage-based methods for detecting and analyzing bacterial pathogens. While specific details about the company's full organizational structure are not provided, its core competency seems to be developing cutting-edge diagnostic technologies that can provide faster and more precise identification of bacterial infections and appropriate antibiotic treatments.
Cobio Diagnostics Inc. has received multiple federal grants primarily from the National Science Foundation (NSF) and the National Institute of Diabetes and Digestive and Kidney Diseases, focusing on developing phage-amplified identification and antimicrobial susceptibility testing technologies. Their most significant recent award is a $984,381 NSF Small Business Innovation Research (SBIR) Phase II Cooperative Agreement aimed at expanding diagnostic technology for rapid identification of major bloodborne bacterial pathogens, specifically the "ESKAPE" pathogens including Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. Previous grants include a $256,000 NSF Project Grant in 2021 and two grants from the National Institute of Diabetes and Digestive and Kidney Diseases in 2020 focused on developing rapid phage-amplified immunoassays for urinary tract infection diagnosis and antimicrobial susceptibility testing. The company's work consistently aims to reduce diagnostic times, improve antibiotic selection, and combat the growing challenge of multidrug-resistant infections by providing faster, more precise diagnostic capabilities directly from patient specimens.
Quick answers
What is Cobio Diagnostics Inc.'s UEI?
Cobio Diagnostics Inc.'s Unique Entity ID (UEI) in SAM.gov is DNNKH7TPCUG3.
What is Cobio Diagnostics Inc.'s CAGE code?
Cobio Diagnostics Inc.'s CAGE code is 8FHN6.
What is Cobio Diagnostics Inc.'s primary NAICS code?
Cobio Diagnostics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Cobio Diagnostics Inc. located?
Cobio Diagnostics Inc.'s physical address in SAM.gov is 12635 E Montview Blvd Rm 219, Aurora, CO 80045, USA.
Is Cobio Diagnostics Inc. registered in SAM.gov?
Yes. Cobio Diagnostics Inc.'s SAM.gov registration is active through September 3, 2027.
What is Cobio Diagnostics Inc.'s most recent federal award?
Cobio Diagnostics Inc.'s most recent federal grant award is Fast-track phage-amplified maldi-TOF MS for rapid phenotypic UTI diagnosis and antimicrobial susceptibility testing -… (R44DK146594), from National Institute of Diabetes and Digestive and Kidney Diseases, on August 21, 2026.
On GovTribe
See Cobio Diagnostics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors